To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Summary

No official summary available for this bill.

Full Text

Legislative Actions

1. 2024-01-31

   Introduced in House

2. 2024-01-31

   Introduced in House

3. 2024-01-31

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

4. 2024-01-31

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

5. 2024-12-17

   Referred to the Subcommittee on Health.